ULM logo
ULM pharmacy professor travels abroad to present groundbreaking research

Published December 19, 2013

Dr. Paul Sylvester, Pfizer Endowed Professor of Pharmacology and Director of Graduate Studies and Research at the University of Louisiana at Monroe, recently traveled to Cartegena, Colombia and Stuttgart, Germany to present his groundbreaking cancer research.

Photo of Dr. Paul Sylvester

“The purpose of the trip [to Cartegena was] to give a presentation on our current research related to tocotrienols—a rare form of Vitamin E that displays potent anticancer activity,” Sylvester said.

During Sylvester’s trip to the University of Hohenheim in Stuttgart, Germany, Sylvester was invited to speak to both undergraduate and graduate students about the anticancer actions of tocotrienols.

Sylvester hopes to continue to present internationally in the hopes that he can establish research collaborations with faculty at the universities around the world.

Sylvester is a member of several scientific, professional and honorary societies including the American Association of Cancer Research (AACR), and The Endocrine Society, Society for Experimental Biology and Medicine.

His research interests include the relationship between nutrition and breast cancer growth and development, and the effects of various forms of vitamin E on breast cancer cells.

In 2011, Sylvester was part of a research team which earned a patent for their discovery of anti-cancer prototype compounds, which are found in the waxy substance on fresh tobacco leaves and which show potential for controlling metastic breast and prostate cancers.

Sylvester received his B.S. from Western Michigan University, Ph.D. from Michigan State University, and completed his Postdoctoral Training at Roswell Park Cancer Institute in Buffalo, NY.

He has taught at ULM for over 15 years.